Press "Enter" to skip to content

Tag: research

What Tony Fauci Told Me About Long COVID and Other Postviral Illnesses

Too many people are suffering from long COVID and other postviral syndromes. Anthony Fauci says we need to step up funding and research now.

Comments closed

Study finds prenatal vaccination protects infants from COVID

Infants as old as 6 months were protected from COVID‑19 infections only when mothers were vaccinated prenatally, and not before pregnancy, according to a new study in JAMA Network Open.

Comments closed

We Interrupt This Mood of Denial to Update COVID’s Threat

Although many Canadians act as though the pandemic has ended, the airborne virus that causes COVID-19 continues to evolve at an amazing pace with devastating consequences for both individuals and the public at large.

Comments closed

Loss of smell, taste after mild COVID improves within 3 years, study shows

Mild COVID-19 infections can cause a loss of taste and smell, but a study today in JAMA Otolaryngology – Head & Neck Surgery suggests that almost all cases resolve within 3 years of initial infection.

Comments closed

New study suggests gargling with salt water may be associated with lower COVID hospitalization

A new study being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Anaheim, California determined that both a low- and high-dose saline regimen appeared to be associated with lower hospitalization rates compared to controls in SARS-CoV-2 infections.

Comments closed

This drug was hailed as a COVID game-changer. Here’s what we know about Paxlovid today

The drug could help people at high risk, writes Dr. Lynora Saxinger. But COVID has changed. Here’s what you should know about the current risks and benefits.

Comments closed

Long COVID linked to allergies in new study

In an analysis of 13 published prospective studies of people of all ages with confirmed SARS-CoV-2 infection who were followed up for at least 12 months, pre-existing allergic conditions were linked to higher risks of experiencing long COVID, according to a study today in Clinical & Experimental Allergy.

Comments closed

Study suggests mass vaccination programs cut COVID cases in Japan 65%

The population benefit of COVID-19 vaccination via direct and indirect effects was substantial in Tokyo in early 2022 during Omicron, with an estimated 65% reduction in the number of SARS-CoV-2 infections, according to a new model that compared risks between unvaccinated and vaccinated individuals.

Comments closed

Childhood abuse linked to higher risk of adult COVID‑19 death

A new study from researchers at the University of Pittsburgh shows adults who suffered childhood abuse or neglect were more likely to be hospitalized for COVID‑19 or die from the virus in adulthood.

Comments closed

Global COVID vaccination saved 2.4 million lives in first 8 months, study estimates

The COVID-19 vaccination campaign in 141 countries averted 2.4 million excess deaths by August 2021 and would have saved another 670,000 more lives had vaccines been distributed equitably, estimates a working paper from University of Southern California (USC) and Brown University researchers.

Comments closed

EPA Testing Shows the Power of DIY Air Filters to Trap Viruses

The results are in: U.S. Environmental Protection Agency research testing of do-it-yourself ‘Corsi-Rosenthal Box’ indoor air filters shows they are 99% effective in removing airborne virus. The ‘Owl Force One’ device tested by the EPA was built by UConn Indoor Air Quality Initiative researchers with Middletown, Connecticut public school children.

Comments closed

Study: Regardless of variant, half of long-COVID patients fail to improve after 18 months

More than 50% of long-COVID patients failed to improve 1.5 years after their initial diagnosis, according to a new study based on cases seen at a Danish post-COVID clinic, both before and after the Omicron variant period.

Comments closed

SARS-CoV-2 virus found to migrate within neurons and infect the brain

The emergence of different variants of SARS-CoV-2 has produced a wide range of clinical profiles and symptoms in patients. For the first time, researchers at the Institut Pasteur and Université Paris Cité have demonstrated, in an animal model, a characteristic common to several SARS-CoV-2 variants: the ability to infect the central nervous system.

Comments closed

How SARS-CoV-2 contributes to heart attacks and strokes

COVID-19 is known to increase the risk of heart attack and stroke. The intense inflammation that occurs throughout the body in severe cases likely contributes to this increased risk. But it’s not clear whether SARS-CoV-2, the virus that causes COVID-19, also affects blood vessels directly.

To find out, an NIH-funded research team, led by Dr. Chiara Giannarelli at New York University School of Medicine, analyzed coronary artery tissue samples from eight people who died of COVID-19 between May 2020 and May 2021. Results appeared in Nature Cardiovascular Research on September 28, 2023.

Comments closed

Researchers estimate 1% or 2% of hospital patients in England caught COVID after admission

During the country’s second COVID wave, 95,000 to 167,000 hospital patients in England were infected with SARS-CoV-2 in the hospital, partly due to a lack of single rooms, suggests a study published yesterday in Nature.

Comments closed

COVID can worsen lower urinary tract symptoms in men

Research in the Journal of Internal Medicine indicates that SARS-CoV-2 infections may worsen lower urinary tract symptoms (LUTS) in men, based on 18,000 men treated for LUTS in Hong Kong in 2021 and 2022.

Comments closed

Risk of Guillain-Barre syndrome 6 times higher after COVID infection, study suggests

A new study from Israel ties COVID-19 infection to an increased risk of a diagnosis of Guillain-Barre syndrome (GBS) within 6 weeks, while mRNA vaccination was linked to a decreased risk of the rare but serious autoimmune disease.

Comments closed